PTPA and neoplasm: Cancerous inhibitor of protein phosphatase 2A (CIP2A), which inhibits protein phosphatase 2A (PP2A) activity, promotes malignant cell transformation and tumor growth by inhibiting the tumor suppressor activity of PP2A (Junttila et al., 2007; Khanna et al., 2013).